Royal Bank of Canada
USNA icon

Royal Bank of Canada’s Usana Health Sciences USNA Stock Holding History

Royal Bank of Canada’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43K Sell
2,452
-276
-10% -$5.48K ﹤0.01% 5567
2025
Q4 		$54K Buy
2,728
+197
+8% +$4.09K ﹤0.01% 5518
2025
Q3 		$70K Sell
2,531
-8,572
-77% -$264K ﹤0.01% 5684
2025
Q2 		$339K Buy
11,103
+1,140
+11% +$32.4K ﹤0.01% 4759
2025
Q1 		$269K Sell
9,963
-91,492
-90% -$2.9M ﹤0.01% 4486
2024
Q4 		$3.64M Buy
101,455
+97,730
+2,624% +$3.65M ﹤0.01% 2572
2024
Q3 		$141K Buy
3,725
+140
+4% +$5.75K ﹤0.01% 5093
2024
Q2 		$162K Sell
3,585
-740
-17% -$34K ﹤0.01% 4927
2024
Q1 		$210K Sell
4,325
-2,018
-32% -$98.8K ﹤0.01% 4650
2023
Q4 		$340K Buy
6,343
+1,407
+29% +$71.2K ﹤0.01% 4618
2023
Q3 		$289K Buy
4,936
+734
+17% +$45.9K ﹤0.01% 4484
2023
Q2 		$265K Buy
4,202
+118
+3% +$7.51K ﹤0.01% 4493
2023
Q1 		$258K Sell
4,084
-1,130
-22% -$67.4K ﹤0.01% 4410
2022
Q4 		$277K Buy
5,214
+1,579
+43% +$85.5K ﹤0.01% 4601
2022
Q3 		$204K Sell
3,635
-579
-14% -$38.3K ﹤0.01% 4757
2022
Q2 		$305K Sell
4,214
-5,336
-56% -$397K ﹤0.01% 4460
2022
Q1 		$758K Sell
9,550
-2,586
-21% -$233K ﹤0.01% 3905
2021
Q4 		$1.23M Buy
12,136
+3,224
+36% +$322K ﹤0.01% 3600
2021
Q3 		$821K Sell
8,912
-1,116
-11% -$107K ﹤0.01% 3895
2021
Q2 		$1.03M Sell
10,028
-2,201
-18% -$221K ﹤0.01% 3615
2021
Q1 		$1.19M Buy
12,229
+1,077
+10% +$98K ﹤0.01% 3426
2020
Q4 		$860K Buy
11,152
+1,427
+15% +$110K ﹤0.01% 3631
2020
Q3 		$717K Sell
9,725
-212
-2% -$17K ﹤0.01% 3542
2020
Q2 		$729K Buy
9,937
+795
+9% +$62.4K ﹤0.01% 3446
2020
Q1 		$528K Buy
9,142
+4,174
+84% +$290K ﹤0.01% 3570
2019
Q4 		$391K Buy
4,968
+620
+14% +$45.7K ﹤0.01% 4143
2019
Q3 		$297K Sell
4,348
-83
-2% -$5.57K ﹤0.01% 4192
2019
Q2 		$352K Sell
4,431
-53
-1% -$4.2K ﹤0.01% 4095
2019
Q1 		$376K Sell
4,484
-8,673
-66% -$905K ﹤0.01% 3941
2018
Q4 		$1.55M Buy
13,157
+8,131
+162% +$940K ﹤0.01% 2831
2018
Q3 		$606K Sell
5,026
-656
-12% -$81.4K ﹤0.01% 3767
2018
Q2 		$655K Sell
5,682
-99
-2% -$10.8K ﹤0.01% 3581
2018
Q1 		$496K Sell
5,781
-46
-0.8% -$3.56K ﹤0.01% 3718
2017
Q4 		$431K Sell
5,827
-1,942
-25% -$130K ﹤0.01% 3897
2017
Q3 		$448K Buy
7,769
+2,791
+56% +$165K ﹤0.01% 3894
2017
Q2 		$319K Sell
4,978
-255
-5% -$15.7K ﹤0.01% 4022
2017
Q1 		$301K Buy
5,233
+255
+5% +$15.2K ﹤0.01% 4061
2016
Q4 		$305K Sell
4,978
-62
-1% -$4.04K ﹤0.01% 4191
2016
Q3 		$349K Sell
5,040
-1,120
-18% -$73.9K ﹤0.01% 4016
2016
Q2 		$344K Buy
6,160
+1,240
+25% +$74.8K ﹤0.01% 4002
2016
Q1 		$298K Sell
4,920
-2,540
-34% -$150K ﹤0.01% 4073
2015
Q4 		$476K Sell
7,460
-26,964
-78% -$1.75M ﹤0.01% 3827
2015
Q3 		$2.31M Buy
34,424
+27,922
+429% +$1.97M ﹤0.01% 2152
2015
Q2 		$444K Buy
6,502
+242
+4% +$15.4K ﹤0.01% 3722
2015
Q1 		$348K Sell
6,260
-2,794
-31% -$143K ﹤0.01% 3811
2014
Q4 		$464K Buy
9,054
+2,794
+45% +$137K ﹤0.01% 3644
2014
Q3 		$231K Hold
6,260
– – ﹤0.01% 4095
2014
Q2 		$245K Hold
6,260
– – ﹤0.01% 4022
2014
Q1 		$236K Sell
6,260
-47,820
-88% -$1.67M ﹤0.01% 3970
2013
Q4 		$2.04M Buy
54,080
+47,626
+738% +$1.82M ﹤0.01% 2296
2013
Q3 		$280K Sell
6,454
-680
-10% -$27.3K ﹤0.01% 3833
2013
Q2 		$258K Buy
+7,134
New +$217K ﹤0.01% 3692

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's USNA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Usana Health Sciences (USNA) stake by 10% in Q1 2026, selling an estimated $5.48K and leaving 2,452 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #5567.

Royal Bank of Canada first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.64M in Q4 2024. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Royal Bank of Canada held 2,452 shares of Usana Health Sciences worth $43K as of Q1 2026.
  • Royal Bank of Canada sold 276 Usana Health Sciences shares in Q1 2026, an estimated $5.48K.
  • Usana Health Sciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5567 holding.
  • Royal Bank of Canada first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Usana Health Sciences position peaked at $3.64M in Q4 2024.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.